comprehensive -WSS

comprehensive

author：hotspot 2025-10-01 23:00:04 - browse：51576

ANDREW YATES/AFP via Getty Images

WASHINGTON — A federal judge in Delaware on Friday ruled against AstraZeneca in a case challenging the constitutionality of Medicare’s new drug price negotiation program.

Colm Connolly, chief judge of the U.S. District Court of Delaware, ruled against the company on all its major arguments. He wrote that AstraZeneca had not proved that Medicare’s new drug price negotiation program jeopardizes its constitutional property rights, and that the company didn’t have standing to challenge the guidance Medicare issued to implement the program.

The case is the first of a slew of cases filed by the pharmaceutical industry and its allies to be decided at the district court level. The Delaware ruling is a blow, as several of the other cases made similar arguments about how the program violates drugmakers’ constitutional property rights.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Humana CEO Bruce Broussard to step down in 2024

leisure time

WSS

How clinical AI models' predictive power can degrade over time

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

STAT Readout: Today's biotech news includes Sana and Amylyx

How clinical AI models' predictive power can degrade over time

European regulators consider appeal over Amylyx ALS drug

Bernie Sanders bashes nonprofit hospitals over their tax breaks

focus

comprehensive

knowledge

Anesthesiologist group: stop taking Ozempic before surgery

The Readout: Amylyx, Alumis, and Lundbeck drug updates

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Peter Marks talks Operation Warp Speed for Rare Diseases

Anesthesiologist group: stop taking Ozempic before surgery

Readout LOUD podcast: Merger Mondays, Ozempic panic

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

How should state employee insurance handle Wegovy?

At least 13 dead in Texas as scorching temps continue

A deep dive into Applied Therapeutics’ data, and questions on Cassava

Wikipedia

STAT Readout Newsletter: Today in biotech, life science news

Just how do doctors, lawmakers, and the public define abortion?

Change Healthcare cyberattack prompts Medicare loan program

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

Medicare to cover more brain scans related to Alzheimer’s drugs

Akero's treatment for NASH falls short in cirrhosis study

hotspot

leisure time

entertainment

hotspot